ReviewMolecular cancer2018

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.

Simona Soverini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.